Galera Therapeutics Inc
GRTX
Get informed when a big investor buys or sells
+ FollowMarket Cap$6.18M
Close$
$12.94
26% downside
Current Fair Value
26% downsideOvervalued by 26% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $6.18 Million |
|---|---|
| Enterprise Value | $677,674.00 |
| Dividend Yield | $- (-) |
| Earnings per Share | $302 |
| Beta | 2.61 |
| Outstanding Shares | 493,114 |
Return
| Return on Equity | 2967.05% |
|---|---|
| Return on Assets | 2417.83% |
| Return on Invested Capital | -45.43% |
Valuation & Multiples
| P/E Ratio | 0.05 |
|---|---|
| PEG | 6.09 |
| Price to Sales | - |
| Price to Book Ratio | 1.75 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -0.3 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 15, 2026
EPS Estimate
$-0.83
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
August 12, 2026
EPS Estimate
$-0.77
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 0.00%▲ 0.00% |
|---|---|
| Total Invested | $4 |
| Investors Holding | 1▲ 1.00% |
ESG Score
No data